Selecta picks up grant for HPV research; Primate deaths spur Ag investigation; Lilly partners on diabetes research;

> Watertown, MA-based Selecta Biosciences has been awarded a $3.2 million grant from the Skolkovo Foundation in support of Selecta's program to develop an SVP immunotherapy to treat cancers caused by infections with Human Papilloma Virus. Release

> The U.S. Department of Agriculture is considering penalizing Covance ($CVD) after the failure of a thermostat override switch on two occasions, killing 13 primates at a South Texas facility. "Covance takes very seriously our ethical and regulatory responsibilities to treat research animals with the utmost care and respect," the company said in a statement to the AP. Report

> Eli Lilly ($LLY) announced a 5-year research partnership with the University of Surrey to study health outcomes, focusing on the effects of treatment in people with Type 2 diabetes. Release